537253 SUNLOC

Sunil Healthcare Share Price

 

 

Start SIP in SUNLOC

Start SIP

Performance

  • Low
  • ₹69
  • High
  • ₹70
  • 52 Week Low
  • ₹61
  • 52 Week High
  • ₹89
  • Open Price₹70
  • Previous Close₹70
  • Volume6
  • 50 DMA₹69.80
  • 100 DMA₹71.74
  • 200 DMA₹73.87

Investment Returns

  • Over 1 Month -3.14%
  • Over 3 Month -8.06%
  • Over 6 Month -12.27%
  • Over 1 Year -6.38%

Smart Investing Starts Here Start SIP with Sunil Healthcare for Steady Growth!

Invest Now

Sunil Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24.8
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 71
  • P/B Ratio
  • 1
  • Average True Range
  • 4.24
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.54
  • RSI
  • 50.16
  • MFI
  • 51.6

Sunil Healthcare Financials

Sunil Healthcare Technicals

EMA & SMA

Current Price
₹69.00
-1 (-1.43%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 6
  • 20 Day
  • ₹68.74
  • 50 Day
  • ₹69.80
  • 100 Day
  • ₹71.74
  • 200 Day
  • ₹73.87

Resistance and Support

69.22 Pivot Speed
  • R3 70.08
  • R2 69.87
  • R1 69.43
  • S1 68.78
  • S2 68.57
  • S3 68.13

Sunil Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-06 Quarterly Results
2025-11-04 Quarterly Results
2025-07-30 Quarterly Results
2025-05-29 Audited Results
2025-02-13 Quarterly Results

Sunil Healthcare F&O

Sunil Healthcare Shareholding Pattern

73.53%
0.1%
17.85%
8.52%

Sunil Healthcare FAQs

Sunil Healthcare share price is ₹69 As on 13 February, 2026 | 02:54

The Market Cap of Sunil Healthcare is ₹70.8 Cr As on 13 February, 2026 | 02:54

The P/E ratio of Sunil Healthcare is 24.8 As on 13 February, 2026 | 02:54

The PB ratio of Sunil Healthcare is 1 As on 13 February, 2026 | 02:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23